company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6702000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,69000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6771000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,155000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,117000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,38000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,16000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,,totalassets,Total Assets,=,debit,usd,6825000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5724000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12824000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4715000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,27630000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50893000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1082000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1082000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51975000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,194810000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-239684000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-276000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-45150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-45150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-45150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,,2011-06-30,2011-08-15 16:10:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6825000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1643000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,170000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1813000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,183000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,119000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,64000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,16000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,,totalassets,Total Assets,=,debit,usd,1893000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5055000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12163000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5247000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,23680000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,46145000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1898000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1898000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,193249000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-239202000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-197000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-46150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-46150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-46150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,,2011-09-30,2011-11-14 14:49:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1893000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,79000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,116000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,201000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,125000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,76000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,34000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,,totalassets,Total Assets,=,debit,usd,226000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4860000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3521000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6992000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23949000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1096000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1096000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25045000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,237300000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-261929000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-24819000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-24819000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-24819000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,,2012-03-31,2012-05-21 11:01:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,226000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,430000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,195000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,260000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,885000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,228000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,128000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,33000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,33000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,,totalassets,Total Assets,=,debit,usd,1018000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13487000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6895000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4437000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5514000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30333000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1343000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1343000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,31676000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,241611000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-272079000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-30658000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-30658000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-30658000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,,2012-06-30,2012-09-12 16:15:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1018000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,111000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,186000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,297000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,462000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,98000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,33000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,33000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,,totalassets,Total Assets,=,debit,usd,428000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8173000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8186000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4680000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36153000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2379000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2379000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,38532000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,250661000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-288575000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-38104000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-38104000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-38104000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,,2012-09-30,2012-11-14 13:08:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,428000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,373000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,39000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,412000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,232000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,140000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,92000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,17000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,17000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,,totalassets,Total Assets,=,debit,usd,521000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,767000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13055000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1083000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1334000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16239000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1316000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1316000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17555000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,11017000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,305631000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-333492000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-28051000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-28051000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-28051000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,,2013-03-31,2013-05-15 17:01:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,521000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1985000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,363000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2348000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,231000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,142000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,89000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,,totalassets,Total Assets,=,debit,usd,2437000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1343000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15309000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1088000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,934000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18674000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18674000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,11017000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,318022000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-345086000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-27254000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-27254000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-27254000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,,2013-06-30,2013-08-14 17:52:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2437000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2857000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,140000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,,totalassets,Total Assets,=,debit,usd,7635000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,667000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10936000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1170000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4447000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4722000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4722000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21942000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,10777000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,343102000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-367996000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-25084000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-25084000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-25084000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,,2013-09-30,2013-11-15 13:11:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7635000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12230000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,147000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,12377000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,80000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,,totalassets,Total Assets,=,debit,usd,12512000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,756000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,35024000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43572000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,43572000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,400058000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-430928000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-31060000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-31060000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-31060000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q1,,2014-03-31,2014-05-15 17:11:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,12512000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8853000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,177000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,12444000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,77000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,,totalassets,Total Assets,=,debit,usd,12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9543000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,655000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,31078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42448000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42448000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,427111000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-456793000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-29872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-29872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-29872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,,2014-06-30,2014-08-15 06:02:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1403000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,167000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1570000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,23914000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2680000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1230000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,,totalassets,Total Assets,=,debit,usd,29394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11504000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,790000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,29831000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43297000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,15717000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,1600000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17317000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60614000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,446806000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-477836000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-190000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-31220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-31220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-31220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,,2014-09-30,2014-11-19 15:25:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,29394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3170000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,879000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,666000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4715000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,41386000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1318000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1939000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3312000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,,totalassets,Total Assets,=,debit,usd,49413000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15575000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7140000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,67081000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,90968000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28996000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,148000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29144000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,120112000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,496513000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-566954000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-258000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-70699000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-70699000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-70699000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,,2015-03-31,2015-05-11 17:21:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,49413000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19202000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1021000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,978000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,21201000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,41999000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,739000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,309000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1048000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,,totalassets,Total Assets,=,debit,usd,64248000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15270000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7388000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,92716000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,116546000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,23724000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,149000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23873000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,140419000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,557214000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-633799000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-76171000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-76171000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-76171000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,,2015-06-30,2015-08-10 17:03:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,64248000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5392000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,747000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,950000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7089000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,43965000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,488000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,97000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,585000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,,totalassets,Total Assets,=,debit,usd,51639000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1172000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22786000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7269000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,56020000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,87247000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,21604000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,144000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21748000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,108995000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,553875000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-47000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-611184000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-57356000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-57356000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-57356000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,,2015-09-30,2015-11-09 16:54:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,51639000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11688000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,746000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1065000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,13499000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,48360000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,214000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,153000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,367000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,,totalassets,Total Assets,=,debit,usd,62226000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1119000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,23891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7389000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,25407000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57806000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10613000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10613000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,68419000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,634798000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,377000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-641368000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-6193000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-6193000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-6193000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,,2016-03-31,2016-05-10 19:46:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,62226000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2143000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,883000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1473000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4499000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,46892000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,77000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,218000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,,totalassets,Total Assets,=,debit,usd,51609000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1119000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,30373000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7541000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,20866000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,59899000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10683000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10683000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,70582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,635656000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,914000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-655543000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-18973000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-18973000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-18973000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,,2016-06-30,2016-08-09 17:10:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,51609000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,802000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,785000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2272000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,46550000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,120000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,120000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,,totalassets,Total Assets,=,debit,usd,48942000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,21087000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25184000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7495000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,198000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53964000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53964000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,678745000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1003000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-684770000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-5022000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-5022000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-5022000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,,2016-09-30,2016-11-10 16:32:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,48942000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1835000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,397000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,923000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3155000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,261000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,44896000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44896000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,,totalassets,Total Assets,=,debit,usd,48312000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,25268000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,35401000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,14104000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,81906000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3047000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3047000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,84953000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,689921000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1534000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-728096000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-36641000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-36641000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-36641000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,,2017-03-31,2017-05-15 17:25:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,48312000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,797000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,819000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,224000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,46340000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46340000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,,totalassets,Total Assets,=,debit,usd,47383000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,17441000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,37522000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,11627000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,72790000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9836000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9836000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,82626000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,702898000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,208000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-738349000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-35243000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-35243000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-35243000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q2,,2017-06-30,2017-08-21 16:37:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,47383000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1051000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1077000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2128000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,188000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,47432000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,47432000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,,totalassets,Total Assets,=,debit,usd,49748000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,11540000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,44948000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,18446000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,81134000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11447000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11447000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,92581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,719140000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-353000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-761620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-42833000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-42833000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-42833000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q3,,2017-09-30,2017-11-20 17:30:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,49748000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,248000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,870000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1118000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,45149000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,67000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,67000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,,totalassets,Total Assets,=,debit,usd,46334000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9423000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25708000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,35807000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,77276000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16197000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16197000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,93473000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,771239000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,385000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-818763000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-47139000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-47139000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-47139000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2018.0,Q3,,2018-09-30,2018-11-16 17:32:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,46334000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16288000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2293000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,18581000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,277000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5612000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5612000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,,totalassets,Total Assets,=,debit,usd,24470000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8646000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,18045000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,47387000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,74216000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,4001000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4749000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8750000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,82966000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,781005000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-840557000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1056000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-58496000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-58496000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-58496000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,,2019-03-31,2019-05-10 17:21:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,24470000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6676000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2230000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,8906000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,355000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5443000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5443000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,,totalassets,Total Assets,=,debit,usd,14704000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13295000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6435000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,35596000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,55464000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7557000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4690000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12247000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67711000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,786200000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-840338000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1131000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-53007000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-53007000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-53007000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,,2019-06-30,2019-08-09 16:21:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,14704000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1970000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2602000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4572000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,365000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5208000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5208000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,,totalassets,Total Assets,=,debit,usd,10145000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13386000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7397000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,32502000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53423000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6652000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4605000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11257000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,64680000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,790022000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-846580000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2023000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-54535000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-54535000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-54535000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,,2019-09-30,2019-11-12 17:17:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,10145000.0
